Q3 2025 Teleflex Inc Earnings Call Transcript
Key Points
- Teleflex Inc (TFX) reported third-quarter revenues of $913 million, marking a 19.4% increase year-over-year on a GAAP basis.
- The Vascular Intervention business performed well, achieving a 6.9% year-over-year reported revenue growth, slightly exceeding expectations.
- The company is making significant progress in its strategy to separate into two independent companies, RemainCo and NewCo, with healthy interest in NewCo's potential sale.
- Teleflex Inc (TFX) saw strong growth in its surgical, interventional, and vascular businesses, particularly in the Americas and EMEA regions.
- The BIOMAG-II trial for the resorbable magnesium scaffold is progressing ahead of schedule, with over 1,000 patients enrolled, indicating strong clinical development momentum.
- The intra-aortic balloon pump revenue growth declined due to lower-than-expected order rates, particularly in the United States, leading to a $30 million reduction in revenue expectations.
- Adjusted gross margin decreased by 350 basis points year-over-year, primarily due to tariffs, foreign exchange rates, and increased logistics costs.
- The interventional urology segment experienced a 14.1% revenue decrease, with continued pressure on the UroLift product.
- OEM revenue decreased by 3.9% year-over-year, driven by customer inventory management challenges.
- Cash flow from operations for the first nine months was significantly lower at $189 million compared to $435.6 million in the prior year, due to unfavorable changes in working capital and other factors.
Good morning, ladies and gentlemen, and welcome to the Teleflex third-quarter 2025 earnings conference call. (Operator Instructions) Please note that this conference call is being recorded and will be available on the company's website for replay shortly.
And now I will turn the call over to Mr. Lawrence Keusch, Vice President of Investor Relations and Strategy Development.
Good morning, everyone, and welcome to the Teleflex Incorporated third-quarter 2025 earnings conference call. The press release and slides to accompany this call are available on our website at teleflex.com. As a reminder, a replay will be available on our website. Those wishing to access the replay can refer to our press release from this morning for details.
Participating on today's call are Liam Kelly, Chairman, President and Chief Executive Officer; and John Deren, Executive Vice President and Chief Financial Officer. Liam and John will provide prepared remarks, and then we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
